Literature DB >> 28549023

Technical Feasibility of a Combined Noncontrast Magnetic Resonance Protocol for Preoperative Transcatheter Aortic Valve Replacement Evaluation.

Paola M Cannaò1,2, Giuseppe Muscogiuri1,3, U Joseph Schoepf1,4, Carlo N De Cecco1, Pal Suranyi1,4, Virginia W Lesslie1, Davide Piccini5,6, Shivraman Giri7, Akos Varga-Szemes1.   

Abstract

PURPOSE: The aim of this study was to prospectively evaluate the technical feasibility of a noncontrast magnetic resonance angiography (MRA) protocol using investigational prototype self-navigated 3D (SN3D) radial whole-heart and quiescent-interval single-shot (QISS) pulse sequences regarding their potential in planning transcatheter aortic valve replacement (TAVR).
MATERIALS AND METHODS: Five patients (76±7 y) with severe aortic valve stenosis and prior computed tomographic angiography (CTA) for TAVR planning and 10 healthy volunteers (28±6 y) underwent noncontrast MRA on a 1.5 T system. A SN3D whole-heart acquisition was used to assess the aortic root anatomy. Evaluation of the aortoiliac access route was performed with both SN3D and QISS. Measurements were compared among SN3D, QISS, and CTA using a paired t test or 1-way analysis of variance. Image quality ratings and contrast-to-noise ratios (CNR) were analyzed using Mann-Whitney U tests. Interobserver agreement was evaluated using Cohen's κ.
RESULTS: The combined SN3D and QISS protocol provided a 10.1±1.6-minute acquisition time. TAVR-relevant evaluation was technically feasible in healthy volunteers. All measurements showed good agreement with CTA in patients (all P>0.098). SN3D and QISS produced similar image quality both in volunteers and in patients (all P>0.122). There was no difference in qualitative ratings between MRA and CTA (all P>0.119). Interobserver agreement was good for MRA (κ=0.71 to 0.76) and excellent for CTA (κ=0.82 to 0.84). Thoracic SN3D provided a similar CNR compared with CTA (P=0.117). CTA yielded higher CNR in the abdominopelvic region compared with QISS (P=0.006).
CONCLUSIONS: A noncontrast MRA protocol combining SN3D and QISS acquisitions for the assessment of cardiac and vascular access route anatomy has technical feasibility for TAVR planning.

Entities:  

Mesh:

Year:  2018        PMID: 28549023     DOI: 10.1097/RTI.0000000000000278

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  4 in total

1.  Multi-parametric approach to predict prosthetic valve size using CMR and clinical data: insights from SAVR.

Authors:  Federico E Mordini; Conor F Hynes; Richard L Amdur; Jeffrey Panting; Dominic A Emerson; Jason Morrissette; Erin Goheen-Thomas; Michael D Greenberg; Gregory D Trachiotis
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-10       Impact factor: 2.357

2.  Accuracy of cardiac magnetic resonance generated 3D models of the aortic annulus compared to cardiovascular computed tomography generated 3D models.

Authors:  Marco Gatti; Aurelio Cosentino; Erik Cura Stura; Laura Bergamasco; Domenica Garabello; Giovanni Pennisi; Mattia Puppo; Stefano Salizzoni; Simona Veglia; Ottavio Davini; Mauro Rinaldi; Paolo Fonio; Riccardo Faletti
Journal:  Int J Cardiovasc Imaging       Date:  2020-05-30       Impact factor: 2.357

3.  Non-contrast MRI protocol for TAVI guidance: quiescent-interval single-shot angiography in comparison with contrast-enhanced CT.

Authors:  Mathias Pamminger; Gert Klug; Christof Kranewitter; Martin Reindl; Sebastian J Reinstadler; Benjamin Henninger; Christina Tiller; Magdalena Holzknecht; Christian Kremser; Axel Bauer; Werner Jaschke; Bernhard Metzler; Agnes Mayr
Journal:  Eur Radiol       Date:  2020-04-22       Impact factor: 5.315

4.  Measurement accuracy of prototype non-contrast, compressed sensing-based, respiratory motion-resolved whole heart cardiovascular magnetic resonance angiography for the assessment of thoracic aortic dilatation: comparison with computed tomography angiography.

Authors:  Basel Yacoub; Robert E Stroud; Davide Piccini; U Joseph Schoepf; John Heerfordt; Jérôme Yerly; Lorenzo Di Sopra; Jonathan D Rollins; D Alan Turner; Tilman Emrich; Fei Xiong; Pal Suranyi; Akos Varga-Szemes
Journal:  J Cardiovasc Magn Reson       Date:  2021-02-08       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.